chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning an 80 year old male who in approx Sept 2004, was vaccinated with a dose pneumococcal 23v polysaccharide vaccine (lot 647654/0865N). Post-vaccination, the pt developed an injection site reaction which included upper arm swelling and redness that persisted for 5 days. Unspecified medical attention was sought. The pt was given unspecified antibiotics to treat an infection in case it is not just a local reaction. The pt's outcome was not reported. The reporter stated that he would like an investigation into the lot to see if other problems were reported. The records of testing prior to release of this lot have been checked by quality assurance and found to be satisfactory. The lot complies with the standards and was released. It was also reported that two female pt's (WAES0410USA01073 and WAES0410USA01074) developed injection site reactions after vaccination with pneumococcal 23v polysaccharide vaccine from the same lot. Additional information has been requested.
Twelve hours after shot, vertigo and dizziness began. Two weeks later I experience daily fatigue, intermittent dizziness, and a noticeable increase in hunger (as though I can never feel full). I'm still able to function daily but the fatigue is very noticeable.
dizziness, fever, chills, nausea, cough, tightness in chest, body aches.
Pfizer-BioNTech COVID-19 Vaccine EUA  Migraines
Antibodies test came back negative after almost a month from the second dose; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (Antibodies test came back negative after almost a month from the second dose) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Leukemia.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (Antibodies test came back negative after almost a month from the second dose). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (Antibodies test came back negative after almost a month from the second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test negative: negative (Negative) Negative.         No relevant concomitant medication was reported.  Treatment information was not provided.
Rash Narrative:  Developed area of rash just distal to injection site about 7 days after vaccination. Described as well demarcated, unknown size (did not envelop all of arm and was limited to anterior area). Associated with warmth and erythema. No other associated symptoms including hives, sloughing, swelling. Area resolved without intervention.
Pats states while driving home she began coughing. cough grad. deepened in chest. By the time she arrived home (1730) Pt took her  BP "87/124" drove herself to ER. States by now shaking, throat on fire and tongue swelling, ER did EKG and sent her home. Dr:" allergic reaction" - very congested at bedtime. Felt fine in AM
21yo  male reports with adverse effects of 1st dose Moderna covid-19 vaccine.  Endorses decreased energy, sore arm, photophobia.  VSS and WNL. Lungs CTAB. CV RRR no MGR.   - reported in VAERS - tylenol 1000mg q8 hours - 24 hours quarters
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 14-OCT-2015, the patient was vaccinated with the involved in the temperature excursion dose of VAQTA (lot # K012457, expiration date 04-JUN-2017; dose and route were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient stated that she started taking Kesimpta in October and has never stopped taking it. She stated that 5 weeks ago she received the Johnson & Johnson vaccine. She said 2-3 weeks after the vaccine she developed psoriasis.
fever; sore arm; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 61-year-old female patient who received Herpes zoster (Shingrix) (batch number 2737P, expiry date 22nd January 2022) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 17th March 2020).   On 7th July 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 8th July 2020, 1 days after receiving Shingrix, the patient experienced fever and pain in arm. On an unknown date, the outcome of the fever and pain in arm were recovered/resolved.   It was unknown if the reporter considered the fever and pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and experienced a sore arm and fever the next day.   The reporter consented to follow up.
have a headache; am feeling tired; general malaise; I had a post viral syndrome; This case was reported by a consumer via call center representative and described the occurrence of headache in a 64-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of headache (refer case US2020AMR047412 for tolerance of 1st dose).   In February 2020, the patient received the 2nd dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced headache, fatigue, malaise and viral syndrome. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the headache, fatigue, malaise and viral syndrome were unknown.   It was unknown if the reporter considered the headache, fatigue, malaise and viral syndrome to be related to Shingrix.  Additional details were provided as follows: The patient received 1std dose about 1 month ago from the date of reporting. After vaccination, the patient felt tired, had headache and general malaise. The patient reported that, felt these symptoms since from 1st dose, but did not relate it at the time and had a full blood work up and nothing showed up. The physician stated that, the patien had post viral syndrome.
headache that lasted for 5 days and was unable to be remedied with OTC medications - no further action taken, symptoms subsided on 9/26/21. Menstrual cycle was to begin on 9/18/21 or 9/19/21 and did not/has not begun as of 10/1/21.
Patient was admitted to Hospital for acute hypoxic respiratory failure secondary to COVID-19 infection and acute kidney injury on 09/05/2021.  Patient was started on dexamethasone he was also anticoagulated with heparin given AKI.  Acute kidney injury suspected to be prerenal secondary to poor oral intake in the setting of COVID-19 infection patient was also taking several medications at home such as Lasix and lisinopril.    Patient required of supplemental oxygenation and fell heated high-flow nasal cannula to refractory hypoxemia then required noninvasive positive pressure ventilation.  He continued to become more hypoxic and MRT was called 9/7/21 for hypoxia with oxygen saturation in the 70s and change in mental status.  Decision was made to intubate the patient.  At this time patient was transferred out of the ICU on mechanical ventilation.  He continued to have worsening acute kidney injury and hyperkalemia which point nephrology was consulted and decision was made to start CRRT.      Concern for superimposed bacterial infection and patient's antibiotics were escalated to cefepime and vancomycin, no growth on cultures. Patient also required norepinephrine intermittently throughout the admission for hypotension.  Patient continued to remain hypoxic despite mechanical ventilation requiring paralytics, proning and was also on nitric oxide.  Nitric oxide was stopped and protein was also stop later of the admission due to skin breakdown.  Fluid removal per CRRT given concerns for volume overload.     Family decided to withdraw care transition to comfort measures only. Patient passed shortly after with family at bedside.  Time of death 1435 September 15, 2020
patient recieved an expired vaccine error due to pfizer labeling. patient reports no adverse reactions yet.
Rash with itching on chest. Consulted primary health provider. He advised rash maybe tow hep B vaccine. NO fever or other adverse reactions reported. Also reported stomach ache, initially. Meds Adderal, Clariten, Confeclar.
Approximately 10 minutes after receiving the vaccination, while walking to his car with his mother, the patient became lightheaded, felt out of it, and needed to sit down.  Mother brought him back to office where he had a brief syncopal episode while sitting with feet elevated.  The momentary syncope lasted only a few seconds, but he continued to feel lightheaded and out of it for an additional 20 minutes and remained fatigued and lightheaded for the next 24 hours.
19 hours after getting the vaccination, my son presented with a skin rash on both arms and on his face. The rash continued to spread over the past week, at times getting better, and then worse again. He was given an oral steroid, as well as a steroid injection. It is now one week after the vaccination and he still has hives/rash.
This spontaneous case reported by a consumer, describes the occurrence of dyspnea (trouble breathing), pain (body aches), headache and fatigue in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# unknown) for COVID-19 immunization. No medical history reported. On Apr 8, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced dyspnea (trouble breathing), pain (body aches), headache and fatigue. At the time of the report, dyspnea (trouble breathing), pain (body aches), headache and fatigue outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported.
Had the shingles vaccine and got shingles/Suspected vaccination failure; Got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID-19 VACCINE (COVID VACCINE) for prophylaxis.   On an unknown date, the patient received Shingles vaccine and the 1st dose of COVID VACCINE. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 30-Sept-2022 Reporter's comment: The case was received from the patient via (Facebook) interactive digital media. The patient had covid vaccine knocked out the shingles vaccine. The patient knew cause got shingles after first covid vaccine and had shingles shingles vaccine. Additional supportive information: It was unknown if the reporter considered the shingles to be related to COVID vaccine. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. As it was not clear that shingles was occurred after or before the shingles vaccine, therefore in worst approach, the case was kept valid with Suspected vaccination failure and shingles considering shingles occurred after shingles vaccine.
Right upper thigh skin graft raised warm 4 by 4 cm welt at injection site.
Fever at first. Then occasional shortness of breath. These have gone away but now have sudden and brief headaches. No treatment.
This spontaneous report was received from a health professional (medical assistant) via company representative regarding a female patient of unknown age. The patient's pertinent medical history, concurrent conditions, drug reaction/ allergies and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with GARDASIL or GARDASIL 9 third dose (strength, anatomical location, frequency, lot # and expiration date were not reported) for prophylaxis. On an unknown date, it was reported that the medical assistant's daughter developed itching and redness at the injection site after receipt of her 3rd dose of GARDASIL or GARDASIL 9 (vaccination site erythema) (vaccination site pruritus). The outcome of the events itching and redness at the injection site was recovered (reported as could not confirm if doses administered were GARDASIL or GARDASIL 9. The causality of the events was not reported. This report was not associated with a product quality complaint.
NUMBNESS; TINGLING; This spontaneous report received from a patient concerned a 72 year old male. The patient's weight, height and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A and expiry: 23-JUN-2021) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced numbness. On APR-2021, the subject experienced tingling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the numbness and tingling was not reported. This report was non-serious. This case, from the same reporter is linked to.
Rash reportedly began around his mouth, spread to neck and chest and forehead. Currently has contiguous erythema in a goatee pattern around mouth and chin, under neck, and blotchy on upper chest, with scattered spots on the head.
Gave student MenQuadfi @ 13:29. Student then lifted her head and then passed out. I guided the student to the floor gently as the student started seizing. She seized for approx 10 seconds. I then rolled her left side. I felt her carotid artery she had no pulse. Due to me being the only one in the office and three other students I yelled asking them to call emergency services from my office phone. By the time they called student was conscience and coughing. i checked her pulse and it was 78.  I explained to her that we called emergency services and the EMS is on their way. EMS took student outside and stated they will be back to let me know if they will take her in.
Pt recv vax on 07/23/98 and on 8/6/98 pt exp blister lesion in the arm and back, febrile, and pt had pneumonia.  Pt transferred to acute unit for intact isolation.
Received Anthrax vaccine on 18Sep04. Noticed excessive swelling reaction on 20Sep04, went to med check and received prescription Cephalex. Swelling progressed went to family physician and received methyl prednisone.
Very sick/keeps getting sick; Power level low and limited/no strength; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old male patient received BNT162b2 (BNT162B2), on 25Oct2021 at 14:00 as dose 2, single (Lot number: FH8020) at the age of 36 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "he is allergic to PCN" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: BNT162b2 (1st dose on 04Oct2021. lot FF2589, got it on arm at approximately 2pm.), administration date: 04Oct2021, when the patient was 36-year-old, for COVID-19 immunization. The following information was reported: ASTHENIA (non-serious) with onset 2021, outcome "not recovered", described as "Power level low and limited/no strength"; ILLNESS (non-serious) with onset 2021, outcome "not recovered", described as "Very sick/keeps getting sick". Therapeutic measures were taken as a result of illness.  Additional information: Was never sick and didn't get Covid 19 before. Got them 1.5-2 years after pandemic because of jobs forcing into vaccination shot. He was worried about losing job. Now aftermath, he wasn't in danger of losing his job. Was completely abused by work making him get vaccination shot. Ever since taking vaccination keeps getting sick. His level of power is not all the way there since he was vaccinated. Got Covid 19 he thinks 3 weeks after vaccinated like 2-3 times. Went to color to get tested and tested positive for Covid 19 directly 3 weeks after 2nd dose. Very sick after that. Has got Covid 19 on record 2 times. Keeps getting sick. Hasn't gotten power back, no strength after vaccinated. Power level low and limited. Noted after Covid 19 twice. Severely sick since 2nd dose. Didn't go back for booster. Severely sick. Scared of getting more shots or boosters. Worked through pandemic and never got vaccinated for couple years or 1-1.5 years, right after he got vaccinated has been ill since. He is very healthy might take Tylenol or Robitussin if sick but very healthy.
This spontaneous report as received from a physician assistant refers to a female patient of unknown age. The patient was vaccinated with dose 1 GARDASIL on 02-AUG-2007 (route, dose and lot # not reported). No other co-suspects were reported. No concomitant medications were reported. ON 05-OCT-2012, the patient was in the office to get the second dose of GARDASIL (route, dose and lot # not reported). No adverse effect was reported. Additional information has been requested.
Started to run a very high fever by the next morning and was lethargic, very cranky which lasted around 8 days. Within the next several days she developed a runny nose, coughing, and would randomly run fever of 100-102. Over the next several weeks personality started to change. She would throw fits and have meltdowns that were inconsolable (PANDAS type behavior/become fixated on one thing). She started to show signs of ADHD and just could not sit still. She developed allergy type symptoms. All of this lasted for 3 years (until I reversed it).
Rt. thigh became erythematous, warm, slight induration.  Temp 98.9 Keflex 250/5ml 1tsp TID X 10 days Compresses Benadryl 12.5/5ml 1tsp q 6 hrs.
Per parent and EMS, patient had a fainting episode.  Blood pressure was checked but everything was fine.  Verified with father 10:00am 10/09/2009.
Red rash occurred 9 days after first vaccine. Raised, itchy, hot, spreading on left arm.
Discharge Provider: DO Primary Care Provider: MD Admission Date: 4/17/2023 Discharge Date: Apr 22, 2023   PRESENTING PROBLEM: Acute respiratory failure with hypoxia (HCC) [J96.01] Acute congestive heart failure, unspecified heart failure type (HCC) [I50.9] AKI (acute kidney injury) (HCC) [N17.9]   HOSPITAL COURSE: Patient is a 67 y.o. who presented to ED via EMS for shortness of breath.  Upon arrival to the ED, He required 2L nasal cannula after sats dropped down to 87% on room air. Significant lab work included mild hyponatremia of 133 and glucose of 138. Procal was WNL at 0.07 and proBNP was 119. D-dimer was mildly elevated at 530. Viral PCR was negative. Chest X-ray showed mild cardiomegaly and pulmonary vascular congestion without acute cardiopulmonary pathology. While in the ED patient received a 1x dose of IV lasix 40 mg.   Patient was admitted to internal medicine service for further workup and treatment of acute hypoxic respiratory failure.  Patient did become hypotensive with acute kidney injury with diuretic therapy.  He underwent an echocardiogram which showed preserved ejection fraction.  He had normal NT proBNP arguing against CHF.  He underwent a CT of the thorax which revealed a multifocal pneumonia.  Viral testing revealed COVID-19 as well as metapneumovirus.  Given his low blood pressures he was also covered empirically for bacterial pneumonia.  Patient was started on 6 mg of dexamethasone and albuterol for wheezing.  He will complete 5 days of Augmentin and azithromycin to cover community-acquired pneumonia.  He clinically improved and was weaned off of oxygen.   Patient underwent a swallow evaluation he was found have significant esophageal dysmotility.  He is tolerating diet and will follow-up with Gastroenterology as an outpatient as well as undergo a video swallow as an outpatient speech-language therapy.   He did exhibit desaturations at night, with sleep apnea suspected, outpatient sleep study recommended, he will discharge on supplemental oxygen to wear at night only.   In regards to his hypertension, patient had significant hypotension during hospitalization.  This has resolved, will hold metoprolol XL as well as losartan and continue hydrochlorothiazide at discharge.  Blood pressure medications can be resumed as tolerated as an outpatient.   Patient is clinically improved and is medically stable for transfer back to his adult foster care facility. He was needing 2 L O2 at night at time of discharge.
Arthralgia   injection site redness, swelling, pain, and itching.  Narrative: Employee reported experiencing joint pain and injection site  redness/pain/swelling/itching about I week after receiving vaccine. Reports saw  an outside provider who prescribed steroids (unknown drug name, dose,  frequency), which she will continue to take until 01/12/2021. As 01 06/2021,  reports ongoing pain in right collar bone, shoulder blade, elbow, wrist, and  tingling in her hand.
Pt describes falling with onset of weakness below the hip level about 6 inches above the patella with missing clonus reflex. The pt cannot squat down with associated observable loss of strength, pt is not able to stand up. The pt has fallen 7 times since symptom onset around lunchtime between 1200 and 1300. Pt denies LOC.
About two weeks after the first shot on July 22,  I noticed my vision was blurry, visited an eye doctor, received an updated prescription and new glasses. The new glasses worked great and I did not make any connection between this change and the vaccine.   However, after receiving the second dose of the vaccine my new glasses no longer seem to be the right prescription. I have slight double vision and it feels like I'm wearing someone else's glasses.  I'm traveling internationally now and cannot visit my eye doctor to check my prescription again.
The first of July, I was having difficulty breathing and chest tightness. I went to an urgent care for an infection in my ankle. They prescribed antibiotics for my ankle. I needed a second round of antibiotics. They told me my blood pressure was high at that time. The chest tightness and difficulty breathing were still present, but they didn?t seem concerned about it. A week later, I started feeling bad and had my son call the ambulance. I threw a clot. I coded in the ambulance. When I woke up, I had been out for a while. I found out I had a heart attack. I received blood pressure medication from the nurse. As I was telling her I felt weird, my vision blurred. I had a stroke in the left occipital lobe. They did a CT scan to see I had a stroke. After about a week in the hospital, they gave my blood thinners and oxygen and sent me home.
Patient seen by PCP 5/11/21 with complaints of rash on neck; diagnosed with shingles.
Dose given after vials stored in dry ice box ran out of batteries, thus deemed compromised by CDC.
chest pain / Heart pain, Lethargy , Brain fog ,coughing , insomnia , headache , nausea
Burned after having the shot-20min. given 11/5/02. Evening-sore arm, weak legs, tired, legs ached. 7th-all day ache, warm area 3" x 15/8-red-raised. Saw MD that afternoon. Stayed home Fri-flu symptoms. Returned to work Mon 11/11/02.